Varian Reports Results for First Quarter of Fiscal Year 2021
Varian Reports Results for First Quarter of Fiscal Year 2021 News provided by Share this article /PRNewswire/ -- First Quarter 2021 Summary Oncology Systems gross orders grew 2% in dollars or 1% in constant currency in the quarter; trailing twelve months gross orders down 5% in dollars or 6% in constant currency 13 Ethos 1 Proton order awarded in China Total company revenues down 6% in dollars, or 8% in constant currency, to $779 million GAAP operating earnings grew 7% at 15.1% of revenues; non-GAAP operating earnings grew 1% at 17.5% of revenues GAAP net earnings per diluted share of $1....